کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1393734 | 983985 | 2012 | 10 صفحه PDF | دانلود رایگان |

SummaryThe marine natural product symplostatin 4 (Sym4) has been recognized as a potent antimalarial agent. However, its mode of action and, in particular, direct targets have to date remained elusive. We report a chemical synthesis of Sym4 and show that Sym4-treatment of P. falciparum-infected red blood cells (RBCs) results in the generation of a swollen food vacuole phenotype and a reduction of parasitemia at nanomolar concentrations. We furthermore demonstrate that Sym4 is a nanomolar inhibitor of the P. falciparum falcipains in infected RBCs, suggesting inhibition of the hemoglobin degradation pathway as Sym4's mode of action. Finally, we reveal a critical influence of the unusual methyl-methoxypyrrolinone (mmp) group of Sym4 for potent inhibition, indicating that Sym4 derivatives with such a mmp moiety might represent viable lead structures for the development of antimalarial falcipain inhibitors.
Graphical AbstractFigure optionsDownload high-quality image (485 K)Download as PowerPoint slideHighlights
► A convergent chemical synthesis of symplostatin 4 (Sym4) and Sym4 derivatives is reported
► Sym4 irreversibly inhibits malarial falcipains in infected red blood cells
► Sym4's unusual methyl-methoxypyrrolinone group is required for nanomolar inhibition of falcipains
Journal: - Volume 19, Issue 12, 21 December 2012, Pages 1546–1555